Blog
RSS FeedPosted by Michael Wonder on 20 Dec 2016
Productivity Commission’s report recommendations would hurt Australian innovation and delay access to breakthrough medicines
20 December 2016 - The Productivity Commission report recommendations, if adopted, would put local jobs, investment and Australian patients’ early ...
Posted by Michael Wonder on 20 Dec 2016
TGA approves new uses for Janssen's Imbruvica
20 December 2016 - The TGA has approved the use of ibrutinib for first-line use in patients with chronic lymphocytic ...
Posted by Michael Wonder on 07 Dec 2016
Correcting the record: Australia Financial Review story on medicinal cannabis
7 December 2016 - On 5 December 2016, the Australian Financial Review ran a story 'Lambert-backed medicinal cannabis grower leaves for ...
Posted by Michael Wonder on 06 Dec 2016
Antizol approved by TGA
5 December 2016 - The TGA has approved a new medicine from AFT Pharmaceuticals. ...
Posted by Michael Wonder on 05 Dec 2016
Nocdurna approved by TGA
5 December 2016 - The TGA has approved a new indication for Ferring's desmopressin acetate. ...
Posted by Michael Wonder on 05 Dec 2016
TGA approves AbbVie's Technivie
5 December 2016 - The TGA has approved another AbbVie combination product for use by patients with chronic hepatitis C ...
Posted by Michael Wonder on 02 Dec 2016
Legislation will improve access to medicines and cut red-tape
2 December 2016 - Legislation introduced to Parliament on final sitting day of 2016 will enable faster access to certain ...
Posted by Michael Wonder on 29 Nov 2016
TGA business plan 2016-17
29 November 2016 - The TGA Business Plan 2016-17 provides an overview of our strategic considerations including: ...
Posted by Michael Wonder on 28 Nov 2016
Updating medicine ingredient names
28 November 2016 - The TGA is updating some medicine ingredient names used in Australia to align with names used ...
Posted by Michael Wonder on 23 Nov 2016
TGA approves extended use of Harvoni
23 November 2016 - The TGÅ has approved the use of Harvoni in additional genotypes. ...
Posted by Michael Wonder on 23 Nov 2016
Belsomra finally approved by TGA
23 November 2016 - The TGA has approved MSD's orexin receptor antagonist. ...
Posted by Michael Wonder on 23 Nov 2016
Halaven cleared by TGA for sarcoma
23 November 2016 - Eisai bags a second use for its halichondrin B analogue. ...
Posted by Michael Wonder on 23 Nov 2016
TGA approves another Opdivo for another cancer type
23 November 2016 - The TGA has sanctioned the use of nivolumab for use by patients with renal cell carcinoma. ...
Posted by Michael Wonder on 17 Nov 2016
TGA approves Ninlaro
17 November 2016 - The TGA has approved Takeda's proteasome inhibitor for use by patients with multiple myeloma. ...
Posted by Michael Wonder on 14 Nov 2016
TGA key performance indicators: July 2015 to June 2016
14 November 2016 - The TGA has published a self-assessed rating of its overall performance for the year ending 30 ...